Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eamaCfbwoceTxOzROOWC

November 21, 2012
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • Many Medicare beneficiaries undergo repeat diagnostic testing
    Between a third and a half of six common diagnostic tests for Medicare patients, including nuclear imaging stress tests, were repeated on patients from 2004 to 2006, according to a study that examined the records of a sample of patients. Researchers reported their results in the Archives of Internal Medicine. Retesting can be medically appropriate, including as a way to monitor whether treatments are working, but it can be a factor in overdiagnosis and adds to health care costs, experts said. HealthDay News (11/19) , MedPage Today(free registration) (11/19) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Is Pricing Low Your Strategy to Success? Think again.
Pricing is the heart of a business. It affects everything you do and is affected by everything you do. Economists talk of supply and demand as key factors behind pricing—successful entrepreneurs manipulate demand by making their products more desirable. These six steps will help you determine the right price for your product or service, read the article and learn how to get pricing right.

  Clinical News & Research 
  • PET, MRI study provides clues on Tourette Syndrome
    Researchers using PET with carbon-11 flumazenil and structural MRI found that patients with Tourette Syndrome have lower binding of gamma-aminobutyric acid-ergic receptors in the ventral striatum, globus pallidus, thalamus, amygdala and right insula. The study findings are consistent with long-held theories about the disease concerning the disinhibition of particular circuits in the brain. Medscape (free registration) (11/20) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  

  Industry Report 
  • IBA sees lower PET, SPECT volume for Q3
    Radiopharmaceutical company Ion Beam Applications reported higher revenue for the third quarter compared with the same period in 2011, owing to a strong equipment segment and dosimetry business. IBA, however, saw weakness in its molecular division, driven by price pressures on FDG-PET radiopharmaceuticals in Europe and a decline in volume of PET in the U.S. and SPECT in Europe. AuntMinnie.com (free registration) (11/20) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Societies update guidelines for stable ischemic heart disease
    An expert panel representing seven health care associations has issued guidelines to update the treatment approach for stable ischemic heart disease. The guidelines include 48 recommendations for diagnosis, risk assessment and treatment. Patients with uninterpretable ECG who can exercise may have an exercise stress with nuclear MPI or echocardiography to address intermediate to high risk of IHD, while patients who can't exercise may have nuclear MPI or echocardiography with pharmacologic stress, according to the guidelines. TCTMD.com (11/19) , TheHeart.org (Montreal)(free registration) (11/19) , Forbes (11/19) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  Advancing Health Care 
 
  • Big Pharma firms work together on clinical databank
    Johnson & Johnson, Merck & Co. and Eli Lilly & Co. are pooling information about clinical investigators in an effort to speed the clinical trial process and avoid repeating one another's efforts. The databank will make information on investigators' clinical practice training available across the three firms, allowing investigators looking into a new indication or disease to forgo training at one firm if they have already had the appropriate training at another. Reducing the administrative burden will effectively expand the pool of investigators, said Dr. Andreas Koester, chief of clinical trial innovation at J&J unit Janssen Research & Development. Pharmalot.com/Pharma Blog (11/16) LinkedInFacebookTwitterEmail this Story
 
  ADVERTISEMENT  
  From SNMMI 
  • Thanks from SNMMI!
    In honor of Thanksgiving, SNMMI would like to say thank you to all of its members, volunteers and partners — in the United States and internationally — for your support of the society. We appreciate your contributions to the field of nuclear medicine and molecular imaging. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  Editor's Note 
  • SmartBrief will not publish Thursday and Friday
    In observance of Thanksgiving in the U.S., SmartBrief will not be published Thursday and Friday. Publication will resume Monday. Enjoy the holiday! LinkedInFacebookTwitterEmail this Story
  SmartQuote 
If the only prayer you said in your whole life was 'thank you,' that would suffice."
--Meister Eckhart,
German theologian and philosopher


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.®  Legal Information